Corbus Pharma (CRBP.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov13

Corbus Pharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.8965 (forecast USD -1.7377)

04:00

Corbus Pharma released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -4.7343

04:00

Oct30

Corbus Pharma Holdings Reports Preliminary Third-Quarter Financial Data

21:32

Corbus Pharma Holdings Plans Registered Public Offering of Stock or Pre-Funding Warrants

21:22

Oct20

Jones Reiterates Strong Buy Rating on Corbus Pharmaceuticals

12:21

Andres Y Maldonado gives Corbus Pharmaceuticals Holdings CRB-701 a Buy Rating

10:31

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -23.34 M, EPS -1.8965

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -17.66 M, EPS -1.4429

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -16.98 M, EPS -1.3914

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More